Axmi-008, a delta-endotoxin gene and methods for its use

ABSTRACT

Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin and delta-endotoxin-associated polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin and delta-endotoxin-associated nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequences shown in SEQ ID NOS:3, 5, and 7, and the nucleotide sequences set forth in SEQ ID NO:1, 2, 4, and 6, as well as variants and fragments thereof.

CROSS REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. application Ser. No.10/781,979, filed Feb. 19, 2004, which claims the benefit of U.S.Provisional Application Ser. No. 60/448,797, filed Feb. 20, 2003, thecontents of which are herein incorporated by reference in theirentirety.

REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY

The official copy of the sequence listing is submitted electronicallyvia EFS-Web as an ASCII formatted sequence listing with a file named“339036_SequenceListing.txt”, created on Feb. 4, 2008, and having a sizeof 184,394 bytes and is filed concurrently with the specification. Thesequence listing contained in this ASCII formatted document is part ofthe specification and is herein incorporated by reference in itsentirety.

FIELD OF THE INVENTION

This invention relates to the field of molecular biology. Provided arenovel genes that encode pesticidal proteins. These proteins and thenucleic acid sequences that encode them are useful in preparingpesticidal formulations and in the production of transgenicpest-resistant plants.

BACKGROUND OF THE INVENTION

Bacillus thuringiensis is a Gram-positive spore forming soil bacteriumcharacterized by its ability to produce crystalline inclusions that arespecifically toxic to certain orders and species of insects, but areharmless to plants and other non-targeted organisms. For this reason,compositions including Bacillus thuringiensis strains or theirinsecticidal proteins can be used as environmentally acceptableinsecticides to control agricultural insect pests or insect vectors fora variety of human or animal diseases.

Crystal (Cry) proteins (delta-endotoxins) from Bacillus thuringiensishave potent insecticidal activity against predominantly Lepidopteran,Dipteran, and Coleopteran larvae. These proteins also have shownactivity against Hymenoptera, Homoptera, Phthiraptera, Mallophaga, andAcari pest orders, as well as other invertebrate orders such asNemathelminthes, Platyhelminthes, and Sarcomastigorphora (Feitelson(1993) The Bacillus Thuringiensis family tree. In Advanced EngineeredPesticides. Marcel Dekker, Inc., New York, N.Y.) These proteins wereoriginally classified as CryI to CryV based primarily on theirinsecticidal activity. The major classes were Lepidoptera-specific (I),Lepidoptera- and Diptera-specific (II), Coleoptera-specific (III),Diptera-specific (IV), and nematode-specific (V) and (VI). The proteinswere further classified into subfamilies; more highly related proteinswithin each family were assigned divisional letters such as Cry1A,Cry1B, Cry1C, etc. Even more closely related proteins within eachdivision were given names such as Cry1C1, Cry1C2, etc.

A new nomenclature was recently described for the Cry genes based uponamino acid sequence homology rather than insect target specificity(Crickmore et al. (1998) Microbiol. Mol. Biol. Rev. 62:807-813). In thenew classification, each toxin is assigned a unique name incorporating aprimary rank (an Arabic number), a secondary rank (an uppercase letter),a tertiary rank (a lowercase letter), and a quaternary rank (anotherArabic number). In the new classification, Roman numerals have beenexchanged for Arabic numerals in the primary rank. Proteins with lessthan 45% sequence identity have different primary ranks, and thecriteria for secondary and tertiary ranks are 78% and 95%, respectively.

The crystal protein does not exhibit insecticidal activity until it hasbeen ingested and solubilized in the insect midgut. The ingestedprotoxin is hydrolyzed by proteases in the insect digestive tract to anactive toxic molecule. (Höfte and Whiteley (1989) Microbiol. Rev.53:242-255). This toxin binds to apical brush border receptors in themidgut of the target larvae and inserts into the apical membranecreating ion channels or pores, resulting in larval death.

Delta-endotoxins generally have five conserved sequence domains, andthree conserved structural domains (see, for example, de Maagd et al.(2001) Trends Genetics 17:193-199). The first conserved structuraldomain consists of seven alpha helices and is involved in membraneinsertion and pore formation. Domain II consists of three beta-sheetsarranged in a Greek key configuration, and domain III consists of twoantiparallel beta-sheets in ‘jelly-roll’ formation (de Maagd et al.(2001) supra). Domains II and III are involved in receptor recognitionand binding, and are therefore considered determinants of toxinspecificity.

Because of the devastation that insects can confer, there is a continualneed to discover new forms of Bacillus thuringiensis delta-endotoxins.

SUMMARY OF INVENTION

Compositions and methods for conferring pesticide resistance tobacteria, plants, plant cells, tissues, and seeds are provided.Compositions include isolated nucleic acid molecules encoding sequencesfor delta-endotoxin and delta-endotoxin-associated polypeptides, vectorscomprising those nucleic acid molecules, and host cells comprising thevectors. Compositions also include isolated or recombinant polypeptidesequences of the endotoxin, compositions comprising these polypeptides,and antibodies to those polypeptides. The nucleotide sequences can beused in DNA constructs or expression cassettes for transformation andexpression in organisms, including microorganisms and plants. Thenucleotide or amino acid sequences may be synthetic sequences that havebeen designed for optimum expression in an organism, including, but notlimited to, a microorganism or a plant. Compositions also comprisetransformed bacteria, plants, plant cells, tissues, and seeds.

In particular, the present invention provides for isolated nucleic acidmolecules comprising a nucleotide sequence encoding an amino acidsequence shown in SEQ ID NO:3, 5, or 7, or a nucleotide sequence setforth in SEQ ID NO:1, 2, 4, or 6, as well as variants and fragmentsthereof. Nucleotide sequences that are complementary to a nucleotidesequence of the invention, or that hybridize to a sequence of theinvention, are also encompassed.

Methods are provided for producing the polypeptides of the invention,and for using those polypeptides for controlling or killing alepidopteran or coleopteran pest.

The compositions and methods of the invention are useful for theproduction of organisms with pesticide resistance, specifically bacteriaand plants. These organisms and compositions derived from them aredesirable for agricultural purposes. The compositions of the inventionare also useful for generating altered or improved delta-endotoxin ordelta-endotoxin-associated proteins that have pesticidal activity, orfor detecting the presence of delta-endotoxin ordelta-endotoxin-associated proteins or nucleic acids in products ororganisms.

DESCRIPTION OF FIGURES

FIGS. 1A, B, C, and D through 1J show an alignment of AXMI-008 (SEQ IDNO:3) with cry1Aa (SEQ ID NO:8), cry1Ac (SEQ ID NO:9), cry1Ia (SEQ IDNO:10), cry2Aa (SEQ ID NO:11), cry3Aa1 (SEQ ID NO:12), cry3Bb (SEQ IDNO:13), cry4Aa (SEQ ID NO:14), cry4Ba (SEQ ID NO:15), cry6Aa (SEQ IDNO:16), cry7Aa (SEQ ID NO:17), cry8Aa (SEQ ID NO:18), cry10Aa (SEQ IDNO:19), cry16Aa (SEQ ID NO:20), cry19Ba (SEQ ID NO:21), cry24Aa (SEQ IDNO:22), cry25Aa (SEQ ID NO:23), cry39Aa1 (SEQ ID NO:24), and cry40Aa1(SEQ ID NO:25). Toxins having C-terminal non-toxic domains wereartificially truncated as shown. Conserved group 1 is found from aboutamino acid residue 185 to about 206 of SEQ ID NO:3. Conserved group 2 isfound from about amino acid residue 276 to about 318 of SEQ ID NO:3.Conserved group 3 is found from about amino acid residue 497 to about547 of SEQ ID NO:3. Conserved group 4 is found from about amino acidresidue 576 to about 586 of SEQ ID NO:3. Conserved group 5 is found fromabout amino acid residue 657 to about 667 of SEQ ID NO:3.

FIGS. 2A and B show an alignment of AXMI-008orf2 (SEQ ID NO:7) withcry19Aa-orf2 (SEQ ID NO:26), crybun2-orf2 (SEQ ID NO:27), crybun3-orf2(SEQ ID NO:28), cry4Aa (SEQ ID NO:14), and cry4Ba (SEQ ID NO:15).

DETAILED DESCRIPTION

The present invention is drawn to compositions and methods forregulating pest resistance in organisms, particularly plants or plantcells. The methods involve transforming organisms with a nucleotidesequence encoding a delta-endotoxin or delta-endotoxin-associatedprotein of the invention. In particular, the nucleotide sequences of theinvention are useful for preparing plants and microorganisms thatpossess pesticidal activity. Thus, transformed bacteria, plants, plantcells, plant tissues and seeds are provided. Compositions aredelta-endotoxin or delta-endotoxin-associated nucleic acids and proteinsof Bacillus thuringiensis. The sequences find use in the construction ofexpression vectors for subsequent transformation into organisms ofinterest, as probes for the isolation of other delta-endotoxin ordelta-endotoxin-associated genes, and for the generation of alteredpesticidal proteins by methods known in the art, such as domain swappingor DNA shuffling. The proteins find use in controlling or killinglepidopteran or coleopteran pest populations and for producingcompositions with pesticidal activity.

DEFINITIONS

By “delta-endotoxin” is intended a toxin from Bacillus thuringiensisthat has toxic activity against one or more pests, including, but notlimited to, members of the Lepidoptera, Diptera, and Coleoptera orders.In some cases, delta-endotoxin proteins have been isolated from otherorganisms, including Clostridium bifermentans and Paenibacilluspopilliae. Delta-endotoxin proteins include amino acid sequences deducedfrom the full-length nucleotide sequences disclosed herein, and aminoacid sequences that are shorter than the full-length sequences, eitherdue to the use of an alternate downstream start site, or due toprocessing that produces a shorter protein having pesticidal activity.Processing may occur in the organism the protein is expressed in, or inthe pest after ingestion of the protein. Delta-endotoxins includeproteins identified as cry1 through cry43, cyt1 and cyt2, and Cyt-liketoxin. There are currently over 250 known species of delta-endotoxinswith a wide range of specificities and toxicities. For an expansive listsee Crickmore et al. (1998), Microbiol. Mol. Biol. Rev. 62:807-813, andfor regular updates see Crickmore et al. (2003) “Bacillus thuringiensistoxin nomenclature,” atwww.biols.susx.ac.uk/Home/Neil_Crickmore/Bt/index.

Bacterial genes, such as the AXMI-008 gene of this invention, quiteoften possess multiple methionine initiation codons in proximity to thestart of the open reading frame. Often, translation initiation at one ormore of these start codons will lead to generation of a functionalprotein. These start codons can include ATG codons. However, bacteriasuch as Bacillus sp. also recognize the codon GTG as a start codon, andproteins that initiate translation at GTG codons contain a methionine atthe first amino acid. Furthermore, it is not often determined a prioriwhich of these codons are used naturally in the bacterium. Thus, it isunderstood that use of one of the alternate methionine codons may alsolead to generation of delta-endotoxin proteins that encode pesticidalactivity. For example, an alternate start site for a delta-endotoxinprotein of the invention may be at nucleotide 177 of SEQ ID NO:1.Translation from this alternate start site results in the amino acidsequence found in SEQ ID NO:5. These delta-endotoxin proteins areencompassed in the present invention and may be used in the methods ofthe present invention.

In addition, there may be one or more additional open reading frames inthe disclosed nucleotide sequences that encode one or moredelta-endotoxin-associated proteins. By “delta-endotoxin-associatedprotein” is intended a protein encoded by a nucleotide sequencedisclosed herein using an alternate open reading frame than that used bythe delta-endotoxins of the present invention. Proteins such as theseare known in the art as helper proteins, stabilizing sequences, ordelta-endotoxin-associated proteins. These delta-endotoxin-associatedproteins may have pesticidal activity, or may be important infacilitating expression of delta-endotoxin proteins. Methods are knownin the art for measuring pesticidal activity and for determining theeffects of delta-endotoxin-associated proteins on delta-endotoxinprotein expression and crystal formation (see, for example, Park et al.(1999) FEMS Microbiol. Lett. 181:319-327; Ge et al. (1998) FEMSMicrobiol. Lett. 165:35-41; Rosso and Delecluse (1997) Appl. Environ.Microbiol. 63:4449-4455). These delta-endotoxin-associated proteins areencompassed by the present invention, and may be used in the methodsdisclosed herein, either alone or in combination with knowndelta-endotoxin proteins. In one embodiment, thedelta-endotoxin-associated protein has the amino acid sequence found inSEQ ID NO:7 and is encoded by the nucleotide sequence of SEQ ID NO:6.

By “plant cell” is intended all known forms of plant, includingundifferentiated tissue (e.g. callus), suspension culture cells,protoplasts, leaf cells, root cells, phloem cells, plant seeds, pollen,propagules, embryos and the like. By “plant expression cassette” isintended a DNA construct that is capable of resulting in the expressionof a protein from an open reading frame in a plant cell. Typically thesecontain a promoter and a coding sequence. Often, such constructs willalso contain a 3′ untranslated region. Such constructs may contain a‘signal sequence’ or ‘leader sequence’ to facilitate co-translational orpost-translational transport of the peptide to certain intracellularstructures such as the chloroplast (or other plastid), endoplasmicreticulum, or Golgi apparatus.

By “signal sequence” is intended a sequence that is known or suspectedto result in cotranslational or post-translational peptide transportacross the cell membrane. In eukaryotes, this typically involvessecretion into the Golgi apparatus, with some resulting glycosylation.By “leader sequence” is intended any sequence that when translated,results in an amino acid sequence sufficient to trigger co-translationaltransport of the peptide chain to a sub-cellular organelle. Thus, thisincludes leader sequences targeting transport and/or glycosylation bypassage into the endoplasmic reticulum, passage to vacuoles, plastidsincluding chloroplasts, mitochondria, and the like.

By “plant transformation vector” is intended a DNA molecule that isnecessary for efficient transformation of a plant cell. Such a moleculemay consist of one or more plant expression cassettes, and may beorganized into more than one ‘vector’ DNA molecule. For example, binaryvectors are plant transformation vectors that utilize two non-contiguousDNA vectors to encode all requisite cis- and trans-acting functions fortransformation of plant cells (Hellens and Mullineaux (2000) Trends inPlant Science 5:446-451). “Vector” refers to a nucleic acid constructdesigned for transfer between different host cells. “Expression vector”refers to a vector that has ability to incorporate, integrate andexpress heterologous DNA sequences or fragments in a foreign cell.

“Transgenic plants” or “transformed plants” or “stably transformedplants or cells or tissues” refers to plants that have incorporated orintegrated exogenous nucleic acid sequences or DNA fragments into theplant cell. These nucleic acid sequences include those that areexogenous, or not present in the untransformed plant cell, as well asthose that may be endogenous, or present in the untransformed plantcell. “Heterologous” generally refers to the nucleic acid sequences thatare not endogenous to the cell or part of the native genome in whichthey are present, and have been added to the cell by infection,transfection, microinjection, electroporation, microprojection, or thelike.

“Promoter” refers to a nucleic acid sequence that functions to directtranscription of a downstream coding sequence. The promoter togetherwith other transcriptional and translational regulatory nucleic acidsequences (also termed “control sequences”) are necessary for theexpression of a DNA sequence of interest.

Provided herein are novel isolated nucleotide sequences that conferpesticidal activity. Also provided are the amino acid sequences for thedelta-endotoxin and delta-endotoxin-associated proteins. The proteinresulting from translation of this gene allows cells to control or killpests that ingest it.

An “isolated” or “purified” nucleic acid molecule or protein, orbiologically active portion thereof, is substantially free of othercellular material, or culture medium when produced by recombinanttechniques, or substantially free of chemical precursors or otherchemicals when chemically synthesized. Preferably, an “isolated” nucleicacid is free of sequences (preferably protein encoding sequences) thatnaturally flank the nucleic acid (i.e., sequences located at the 5′ and3′ ends of the nucleic acid) in the genomic DNA of the organism fromwhich the nucleic acid is derived. For purposes of the invention,“isolated” when used to refer to nucleic acid molecules excludesisolated chromosomes. For example, in various embodiments, the isolateddelta-endotoxin or delta-endotoxin-associated-encoding nucleic acidmolecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5kb, or 0.1 kb of nucleotide sequence that naturally flanks the nucleicacid molecule in genomic DNA of the cell from which the nucleic acid isderived. A delta-endotoxin or delta-endotoxin-associated protein that issubstantially free of cellular material includes preparations of proteinhaving less than about 30%, 20%, 10%, or 5% (by dry weight) ofnon-delta-endotoxin or non-delta-endotoxin-associated protein (alsoreferred to herein as a “contaminating protein”). Various aspects of theinvention are described in further detail in the following subsections.

Isolated Nucleic Acid Molecules, and Variants and Fragments Thereof

One aspect of the invention pertains to isolated nucleic acid moleculescomprising nucleotide sequences encoding delta-endotoxin ordelta-endotoxin-associated proteins and polypeptides or biologicallyactive portions thereof, as well as nucleic acid molecules sufficientfor use as hybridization probes to identify delta-endotoxin ordelta-endotoxin-associated-encoding nucleic acids. As used herein, theterm “nucleic acid molecule” is intended to include DNA molecules (e.g.,cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and analogs of theDNA or RNA generated using nucleotide analogs. The nucleic acid moleculecan be single-stranded or double-stranded, but preferably isdouble-stranded DNA.

Nucleotide sequences encoding the proteins of the present inventioninclude the sequences set forth in SEQ ID NOS:1, 2, 4, and 6, andcomplements thereof. By “complement” is intended a nucleotide sequencethat is sufficiently complementary to a given nucleotide sequence suchthat it can hybridize to the given nucleotide sequence to thereby form astable duplex. The corresponding amino acid sequences for thedelta-endotoxin or delta-endotoxin-associated proteins encoded by thesenucleotide sequences are set forth in SEQ ID NOS:3, 5, and 7.

Nucleic acid molecules that are fragments of these delta-endotoxin ordelta-endotoxin-associated protein-encoding nucleotide sequences arealso encompassed by the present invention. By “fragment” is intended aportion of the nucleotide sequence encoding a delta-endotoxin protein ordelta-endotoxin-associated protein. A fragment of a nucleotide sequencemay encode a biologically active portion of a delta-endotoxin ordelta-endotoxin-associated protein, or it may be a fragment that can beused as a hybridization probe or PCR primer using methods disclosedbelow. Nucleic acid molecules that are fragments of a delta-endotoxin ora delta-endotoxin-associated nucleotide sequence comprise at least about15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700,750, 800, 850, 900, 950, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700,1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 3000, 3500, 4000, 4500,5000, 5500 nucleotides, or up to the number of nucleotides present in afull-length delta-endotoxin or delta-endotoxin-associatedprotein-encoding nucleotide sequence disclosed herein (for example, 5980nucleotides for SEQ ID NO:1, 2082 for SEQ ID NO:2, 2073 for SEQ ID NO:4,or 1686 for SEQ ID NO:6), depending upon the intended use.

Fragments of the nucleotide sequences of the present invention willencode protein fragments that retain the biological activity of thedelta-endotoxin or delta-endotoxin-associated protein and, hence, retainpesticidal activity or delta-endotoxin-associated protein activity,respectively. By “delta-endotoxin activity” is intended pesticidalactivity. By “delta-endotoxin-associated protein activity” is intendedthat the protein have pesticidal activity, or that the protein improvesexpression of a delta-endotoxin protein. This improvement in proteinexpression can happen by any mechanism. By “retains activity” isintended that the fragment will have at least about 30%, preferably atleast about 50%, more preferably at least about 70%, even morepreferably at least about 80% of the activity of the delta-endotoxin ordelta-endotoxin-associated protein. Methods are known in the art fordetermining the effects of delta-endotoxin-associated proteins ondelta-endotoxin protein expression and crystal formation (see, forexample, Park et al. (1999) FEMS Microbiol. Lett. 181:319-327; Ge et al.(1998) FEMS Microbiol. Lett. 165:35-41; Rosso and Delecluse (1997) Appl.Environ. Microbiol. 63:4449-4455). Methods for measuring pesticidalactivity are well known in the art. See, for example, Czapla and Lang(1990) J. Econ. Entomol. 83(6): 2480-2485; Andrews et al. (1988)Biochem. J. 252:199-206; Marrone et al. (1985) J. of Economic Entomology78:290-293; and U.S. Pat. No. 5,743,477, all of which are hereinincorporated by reference in their entirety.

A fragment of a delta-endotoxin or delta-endotoxin-associatedprotein-encoding nucleotide sequence that encodes a biologically activeportion of a protein of the invention will encode at least about 15, 25,30, 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400, 450, 500, 550,600, or 650 contiguous amino acids, or up to the total number of aminoacids present in a full-length delta-endotoxin ordelta-endotoxin-associated protein of the invention (for example, 693amino acids for SEQ ID NO:3, 690 amino acids for SEQ ID NO:5, or 561amino acids for SEQ ID NO:7).

Preferred delta-endotoxin or delta-endotoxin-associated proteins of thepresent invention are encoded by a nucleotide sequences sufficientlyidentical to the nucleotide sequences of SEQ ID NO:1, 2, 4, or 6. By“sufficiently identical” is intended an amino acid or nucleotidesequence that has at least about 60% or 65% sequence identity,preferably about 70% or 75% sequence identity, more preferably about 80%or 85% sequence identity, most preferably about 90%, 91%, 92%, 93%, 94%,95%, 96%, 97%, 98% or 99% sequence identity compared to a referencesequence using one of the alignment programs described herein usingstandard parameters. One of skill in the art will recognize that thesevalues can be appropriately adjusted to determine corresponding identityof proteins encoded by two nucleotide sequences by taking into accountcodon degeneracy, amino acid similarity, reading frame positioning, andthe like.

To determine the percent identity of two amino acid sequences or of twonucleic acids, the sequences are aligned for optimal comparisonpurposes. The percent identity between the two sequences is a functionof the number of identical positions shared by the sequences (i.e.,percent identity=number of identical positions/total number of positions(e.g., overlapping positions)×100). In one embodiment, the two sequencesare the same length. The percent identity between two sequences can bedetermined using techniques similar to those described below, with orwithout allowing gaps. In calculating percent identity, typically exactmatches are counted.

The determination of percent identity between two sequences can beaccomplished using a mathematical algorithm. A nonlimiting example of amathematical algorithm utilized for the comparison of two sequences isthe algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA87:2264, modified as in Karlin and Altschul (1993) Proc. Natl. Acad.Sci. USA 90:5873-5877. Such an algorithm is incorporated into the BLASTNand BLASTX programs of Altschul et al. (1990) J. Mol. Biol. 215:403.BLAST nucleotide searches can be performed with the BLASTN program,score=100, wordlength=12, to obtain nucleotide sequences homologous todelta-endotoxin or delta-endotoxin-associated nucleic acid molecules ofthe invention. BLAST protein searches can be performed with the BLASTXprogram, score=50, wordlength=3, to obtain amino acid sequenceshomologous to delta-endotoxin or delta-endotoxin-associated proteinmolecules of the invention. To obtain gapped alignments for comparisonpurposes, Gapped BLAST can be utilized as described in Altschul et al.(1997) Nucleic Acids Res. 25:3389. Alternatively, PSI-Blast can be usedto perform an iterated search that detects distant relationships betweenmolecules. See, Altschul et al. (1997) supra. When utilizing BLAST,Gapped BLAST, and PSI-Blast programs, the default parameters of therespective programs (e.g., BLASTX and BLASTN) can be used. See,www.ncbi.nlm.nih.gov. Another non-limiting example of a mathematicalalgorithm utilized for the comparison of sequences is the ClustalWalgorithm (Higgins et al. (1994) Nucleic Acids Res. 22:4673-4680).ClustalW compares sequences and aligns the entirety of the amino acid orDNA sequence, and thus can provide data about the sequence conservationof the entire amino acid sequence. The ClustalW algorithm is used inseveral commercially available DNA/amino acid analysis softwarepackages, such as the ALIGNX module of the vector NTi Program Suite(Informax, Inc). After alignment of amino acid sequences with ClustalW,the percent amino acid identity can be assessed. A non-limiting exampleof a software program useful for analysis of ClustalW alignments isGeneDoc™. Genedoc™ (Karl Nicholas) allows assessment of amino acid (orDNA) similarity and identity between multiple proteins. Anothernon-limiting example of a mathematical algorithm utilized for thecomparison of sequences is the algorithm of Myers and Miller (1988)CABIOS 4:11-17. Such an algorithm is incorporated into the ALIGN program(version 2.0), which is part of the GCG sequence alignment softwarepackage (available from Accelrys, Inc., 9865 Scranton Rd., San Diego,Calif., USA). When utilizing the ALIGN program for comparing amino acidsequences, a PAM120 weight residue table, a gap length penalty of 12,and a gap penalty of 4 can be used.

The invention also encompasses variant nucleic acid molecules.“Variants” of the delta-endotoxin or delta-endotoxin-associatedprotein-encoding nucleotide sequences include those sequences thatencode the delta-endotoxin or delta-endotoxin-associated proteinsdisclosed herein but that differ conservatively because of thedegeneracy of the genetic code as well as those that are sufficientlyidentical as discussed above. Naturally occurring allelic variants canbe identified with the use of well-known molecular biology techniques,such as polymerase chain reaction (PCR) and hybridization techniques asoutlined below. Variant nucleotide sequences also include syntheticallyderived nucleotide sequences that have been generated, for example, byusing site-directed mutagenesis but which still encode thedelta-endotoxin or delta-endotoxin-associated proteins disclosed in thepresent invention as discussed below. Variant proteins encompassed bythe present invention are biologically active, that is they continue topossess the desired biological activity of the native protein, that is,retaining pesticidal activity. By “retains activity” is intended thatthe variant will have at least about 30%, preferably at least about 50%,more preferably about at least 70%, even more preferably at least about80% of the activity of the native protein. Methods for measuringpesticidal activity are well known in the art. See, for example, Czaplaand Lang (1990) J. Econ. Entomol. 83(6): 2480-2485; Andrews et al.(1988) Biochem. J. 252:199-206; Marrone et al. (1985) J. of EconomicEntomology 78:290-293; and U.S. Pat. No. 5,743,477, all of which areherein incorporated by reference in their entirety.

The invention also encompasses variant nucleic acid molecules.“Variants” of the delta-endotoxin or delta-endotoxin-associated-encodingnucleotide sequences include those sequences that encode thedelta-endotoxin or delta-endotoxin-associated proteins disclosed hereinbut that differ conservatively because of the degeneracy of the geneticcode as well as those that are sufficiently identical as discussedabove. Naturally occurring allelic variants can be identified with theuse of well-known molecular biology techniques, such as polymerase chainreaction (PCR) and hybridization techniques as outlined below. Variantnucleotide sequences also include synthetically derived nucleotidesequences that have been generated, for example, by using site-directedmutagenesis but which still encode the delta-endotoxin ordelta-endotoxin-associated proteins disclosed in the present inventionas discussed below.

The skilled artisan will further appreciate that changes can beintroduced by mutation into the nucleotide sequences of the inventionthereby leading to changes in the amino acid sequence of the encodeddelta-endotoxin or delta-endotoxin-associated proteins, without alteringthe biological activity of the proteins. Thus, variant isolated nucleicacid molecules can be created by introducing one or more nucleotidesubstitutions, additions, or deletions into the corresponding nucleotidesequence disclosed herein, such that one or more amino acidsubstitutions, additions or deletions are introduced into the encodedprotein. Mutations can be introduced by standard techniques, such assite-directed mutagenesis and PCR-mediated mutagenesis. Such variantnucleotide sequences are also encompassed by the present invention.

For example, preferably, conservative amino acid substitutions may bemade at one or more predicted, preferably nonessential amino acidresidues. A “nonessential” amino acid residue is a residue that can bealtered from the wild-type sequence of a delta-endotoxin ordelta-endotoxin-associated protein without altering the biologicalactivity, whereas an “essential” amino acid residue is required forbiological activity. A “conservative amino acid substitution” is one inwhich the amino acid residue is replaced with an amino acid residuehaving a similar side chain. Families of amino acid residues havingsimilar side chains have been defined in the art. These families includeamino acids with basic side chains (e.g., lysine, arginine, histidine),acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polarside chains (e.g., glycine, asparagine, glutamine, serine, threonine,tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine,leucine, isoleucine, proline, phenylalanine, methionine, tryptophan),beta-branched side chains (e.g., threonine, valine, isoleucine) andaromatic side chains (e.g., tyrosine, phenylalanine, tryptophan,histidine).

There are generally five highly conserved regions among thedelta-endotoxin proteins, concentrated largely in the center of thedomain or at the junction between domains (Rajamohan et al. (1998) Prog.Nucleic Acid Res. Mol. Biol. 60:1-23). The blocks of conserved aminoacids for various delta-endotoxins as well as consensus sequences may befound in Schnepf et al. (1998) Microbio. Mol. Biol. Rev. 62:775-806 andLereclus et al. (1989) Role, Structure, and Molecular Organization ofthe Genes Coding for the Parasporal d-endotoxins of Bacillusthuringiensis. In Regulation of Procaryotic Development. Issar Smit,Slepecky, R. A., Setlow, P. American Society for Microbiology,Washington, D.C. 20006. It has been proposed that delta-endotoxinshaving these conserved regions may share a similar structure, consistingof three domains (Li et al. (1991) Nature 353: 815-821). Domain I hasthe highest similarity between delta-endotoxins (Bravo (1997) J.Bacteriol. 179:2793-2801).

Amino acid substitutions may be made in nonconserved regions that retainfunction. In general, such substitutions would not be made for conservedamino acid residues, or for amino acid residues residing within aconserved motif, where such residues are essential for protein activity.Examples of residues that are conserved and that may be essential forprotein activity include, for example, residues that are identicalbetween all proteins contained in the alignment of FIGS. 1A, B, C, and Dthrough 1J or 2A and B. Examples of residues that are conserved but thatmay allow conservative amino acid substitutions and still retainactivity include, for example, residues that have only conservativesubstitutions between all proteins contained in the alignment of FIGS.1A, B, C, and D through 1J or 2A and B. However, one of skill in the artwould understand that functional variants may have minor conserved ornonconserved alterations in the conserved residues.

Alternatively, variant nucleotide sequences can be made by introducingmutations randomly along all or part of the coding sequence, such as bysaturation mutagenesis, and the resultant mutants can be screened forability to confer delta-endotoxin or delta-endotoxin-associated activityto identify mutants that retain activity. Following mutagenesis, theencoded protein can be expressed recombinantly, and the activity of theprotein can be determined using standard assay techniques.

Using methods such as PCR, hybridization, and the like correspondingdelta-endotoxin or delta-endotoxin-associated sequences can beidentified, such sequences having substantial identity to the sequencesof the invention. See, for example, Sambrook J., and Russell, D. W.(2001) Molecular Cloning: A Laboratory Manual. (Cold Spring HarborLaboratory Press, Cold Spring Harbor, N.Y.) and Innis, et al. (1990) PCRProtocols: A Guide to Methods and Applications (Academic Press, NY).

In a hybridization method, all or part of the delta-endotoxin ordelta-endotoxin-associated nucleotide sequence can be used to screencDNA or genomic libraries. Methods for construction of such cDNA andgenomic libraries are generally known in the art and are disclosed inSambrook and Russell, 2001. The so-called hybridization probes may begenomic DNA fragments, cDNA fragments, RNA fragments, or otheroligonucleotides, and may be labeled with a detectable group such as³²P, or any other detectable marker, such as other radioisotopes, afluorescent compound, an enzyme, or an enzyme co-factor. Probes forhybridization can be made by labeling synthetic oligonucleotides basedon the known delta-endotoxin or delta-endotoxin-associated-encodingnucleotide sequence disclosed herein. Degenerate primers designed on thebasis of conserved nucleotides or amino acid residues in the nucleotidesequence or encoded amino acid sequence can additionally be used. Theprobe typically comprises a region of nucleotide sequence thathybridizes under stringent conditions to at least about 12, preferablyabout 25, more preferably at least about 50, 75, 100, 125, 150, 175,200, 250, 300, 350, or 400 consecutive nucleotides of delta-endotoxin ordelta-endotoxin-associated-encoding nucleotide sequence of the inventionor a fragment or variant thereof. Preparation of probes forhybridization is generally known in the art and is disclosed in Sambrookand Russell, 2001, herein incorporated by reference.

In hybridization techniques, all or part of a known nucleotide sequenceis used as a probe that selectively hybridizes to other correspondingnucleotide sequences present in a population of cloned genomic DNAfragments or cDNA fragments (i.e., genomic or cDNA libraries) from achosen organism. The hybridization probes may be genomic DNA fragments,cDNA fragments, RNA fragments, or other oligonucleotides, and may belabeled with a detectable group such as ³²P, or any other detectablemarker. Thus, for example, probes for hybridization can be made bylabeling synthetic oligonucleotides based on the delta-endotoxin ordelta-endotoxin-associated sequence of the invention. Methods forpreparation of probes for hybridization and for construction of cDNA andgenomic libraries are generally known in the art and are disclosed inSambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed.,Cold Spring Harbor Laboratory Press, Plainview, N.Y.).

For example, the entire delta-endotoxin or delta-endotoxin-associatedsequence disclosed herein, or one or more portions thereof, may be usedas a probe capable of specifically hybridizing to correspondingdelta-endotoxin or delta-endotoxin-associated-like sequences andmessenger RNAs. To achieve specific hybridization under a variety ofconditions, such probes include sequences that are unique and arepreferably at least about 10 nucleotides in length, and most preferablyat least about 20 nucleotides in length. Such probes may be used toamplify corresponding delta-endotoxin or delta-endotoxin-associatedsequences from a chosen organism by PCR. This technique may be used toisolate additional coding sequences from a desired organism or as adiagnostic assay to determine the presence of coding sequences in anorganism. Hybridization techniques include hybridization screening ofplated DNA libraries (either plaques or colonies; see, for example,Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed.,Cold Spring Harbor Laboratory Press, Plainview, N.Y.).

Hybridization of such sequences may be carried out under stringentconditions. By “stringent conditions” or “stringent hybridizationconditions” is intended conditions under which a probe will hybridize toits target sequence to a detectably greater degree than to othersequences (e.g., at least 2-fold over background). Stringent conditionsare sequence-dependent and will be different in different circumstances.By controlling the stringency of the hybridization and/or washingconditions, target sequences that are 100% complementary to the probecan be identified (homologous probing). Alternatively, stringencyconditions can be adjusted to allow some mismatching in sequences sothat lower degrees of similarity are detected (heterologous probing).Generally, a probe is less than about 1000 nucleotides in length,preferably less than 500 nucleotides in length.

Typically, stringent conditions will be those in which the saltconcentration is less than about 1.5 M Na ion, typically about 0.01 to1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and thetemperature is at least about 30° C. for short probes (e.g., 10 to 50nucleotides) and at least about 60° C. for long probes (e.g., greaterthan 50 nucleotides). Stringent conditions may also be achieved with theaddition of destabilizing agents such as formamide. Exemplary lowstringency conditions include hybridization with a buffer solution of 30to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulphate) at 37° C.,and a wash in 1× to 2×SSC (20×SSC=3.0 M NaCl/0.3 M trisodium citrate) at50 to 55° C. Exemplary moderate stringency conditions includehybridization in 40 to 45% formamide, 1.0 M NaCl, 1% SDS at 37° C., anda wash in 0.5× to 1×SSC at 55 to 60° C. Exemplary high stringencyconditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at37° C., and a wash in 0.1×SSC at 60 to 65° C. Optionally, wash buffersmay comprise about 0.1% to about 1% SDS. Duration of hybridization isgenerally less than about 24 hours, usually about 4 to about 12 hours.

Specificity is typically the function of post-hybridization washes, thecritical factors being the ionic strength and temperature of the finalwash solution. For DNA-DNA hybrids, the T_(m) can be approximated fromthe equation of Meinkoth and Wahl (1984) Anal. Biochem. 138:267-284:T_(m)=81.5° C.+16.6 (log M)+0.41 (% GC)−0.61 (% form)-500/L; where M isthe molarity of monovalent cations, % GC is the percentage of guanosineand cytosine nucleotides in the DNA, % form is the percentage offormamide in the hybridization solution, and L is the length of thehybrid in base pairs. The T_(m) is the temperature (under defined ionicstrength and pH) at which 50% of a complementary target sequencehybridizes to a perfectly matched probe. T_(m) is reduced by about 1° C.for each 1% of mismatching; thus, T_(m), hybridization, and/or washconditions can be adjusted to hybridize to sequences of the desiredidentity. For example, if sequences with >90% identity are sought, theT_(m) can be decreased 10° C. Generally, stringent conditions areselected to be about 5° C. lower than the thermal melting point (T_(m))for the specific sequence and its complement at a defined ionic strengthand pH. However, severely stringent conditions can utilize ahybridization and/or wash at 1, 2, 3, or 4° C. lower than the thermalmelting point (T_(m)); moderately stringent conditions can utilize ahybridization and/or wash at 6, 7, 8, 9, or 10° C. lower than thethermal melting point (T_(m)); low stringency conditions can utilize ahybridization and/or wash at 11, 12, 13, 14, 15, or 20° C. lower thanthe thermal melting point (T_(m)). Using the equation, hybridization andwash compositions, and desired T_(m), those of ordinary skill willunderstand that variations in the stringency of hybridization and/orwash solutions are inherently described. If the desired degree ofmismatching results in a T_(m) of less than 45° C. (aqueous solution) or32° C. (formamide solution), it is preferred to increase the SSCconcentration so that a higher temperature can be used. An extensiveguide to the hybridization of nucleic acids is found in Tijssen (1993)Laboratory Techniques in Biochemistry and MolecularBiology—Hybridization with Nucleic Acid Probes, Part I, Chapter 2(Elsevier, N.Y.); and Ausubel et al., eds. (1995) Current Protocols inMolecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience,New York). See Sambrook et al. (1989) Molecular Cloning: A LaboratoryManual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.).

Isolated Proteins and Variants and Fragments Thereof

Delta-endotoxin and delta-endotoxin-associated proteins are alsoencompassed within the present invention. By “delta-endotoxin protein”is intended a protein having the amino acid sequence set forth in SEQ IDNO:3 or 5. By “delta-endotoxin-associated protein” is intended a proteinhaving the amino acid sequence set forth in SEQ ID NO:7. Fragments,biologically active portions, and variants thereof are also provided,and may be used to practice the methods of the present invention.

“Fragments” or “biologically active portions” include polypeptidefragments comprising a portion of an amino acid sequence encoding adelta-endotoxin or delta-endotoxin-associated protein as set forth inSEQ ID NO:3, 5, or 7, and that retain delta-endotoxin activity ordelta-endotoxin-associated activity. A biologically active portion of adelta-endotoxin or delta-endotoxin-associated protein can be apolypeptide that is, for example, 10, 25, 50, 100 or more amino acids inlength. Such biologically active portions can be prepared by recombinanttechniques and evaluated for delta-endotoxin ordelta-endotoxin-associated activity. Methods for measuring pesticidalactivity are well known in the art. See, for example, Czapla and Lang(1990) J. Econ. Entomol. 83(6): 2480-2485; Andrews et al. (1988)Biochem. J. 252:199-206; Marrone et al. (1985) J. of Economic Entomology78:290-293; and U.S. Pat. No. 5,743,477, all of which are hereinincorporated by reference in their entirety. As used here, a fragmentcomprises at least 8 contiguous amino acids SEQ ID NO:3, 5, or 7. Theinvention encompasses other fragments, however, such as any fragment inthe protein greater than about 10, 20, 30, 50, 100, 150, 200, 250, 300,350, 400, 450, 500, 550, 600, and 650 amino acids.

By “variants” is intended proteins or polypeptides having an amino acidsequence that is at least about 60%, 65%, preferably about 70%, 75%,more preferably about 80%, 85%, most preferably about 90%, 91%, 92%,93%, 94%, 95%, 96%, 97%, 98% or 99% identical to the amino acid sequenceof SEQ ID NO:3, 5, or 7. Variants also include polypeptides encoded by anucleic acid molecule that hybridizes to the nucleic acid molecule ofSEQ ID NO:1, 2, 4, or 6, or a complement thereof, under stringentconditions. Such variants generally retain delta-endotoxin ordelta-endotoxin-associated activity. Variants include polypeptides thatdiffer in amino acid sequence due to mutagenesis. Variant proteinsencompassed by the present invention are biologically active, that isthey continue to possess the desired biological activity of the nativeprotein, that is, retaining pesticidal activity. Methods for measuringpesticidal activity are well known in the art. See, for example, Czaplaand Lang (1990) J. Econ. Entomol. 83(6): 2480-2485; Andrews et al.(1988) Biochem. J. 252:199-206; Marrone et al. (1985) J. of EconomicEntomology 78:290-293; and U.S. Pat. No. 5,743,477, all of which areherein incorporated by reference in their entirety.

Altered or Improved Variants

It is recognized that DNA sequences of a delta-endotoxin ordelta-endotoxin-associated protein may be altered by various methods,and that these alterations may result in DNA sequences encoding proteinswith amino acid sequences different than that encoded by thedelta-endotoxin or delta-endotoxin-associated protein of the presentinvention. This protein may be altered in various ways including aminoacid substitutions, deletions, truncations, and insertions. Methods forsuch manipulations are generally known in the art. For example, aminoacid sequence variants of the delta-endotoxin ordelta-endotoxin-associated protein can be prepared by mutations in theDNA. This may also be accomplished by one of several forms ofmutagenesis and/or in directed evolution. In some aspects, the changesencoded in the amino acid sequence will not substantially affect thefunction of the protein. Such variants will possess the desiredpesticidal activity. However, it is understood that the ability of adelta-endotoxin or delta-endotoxin-associated protein to conferpesticidal activity may be improved by the use of such techniques uponthe compositions of this invention. For example, one may express thedelta-endotoxin or delta-endotoxin-associated protein in host cells thatexhibit high rates of base misincorporation during DNA replication, suchas XL-1 Red (Stratagene). After propagation in such strains, one canisolate the delta-endotoxin or delta-endotoxin-associated DNA (forexample by preparing plasmid DNA, or by amplifying by PCR and cloningthe resulting PCR fragment into a vector), culture the delta-endotoxinor delta-endotoxin-associated mutations in a non-mutagenic strain, andidentify mutated delta-endotoxin or delta-endotoxin-associated geneswith pesticidal activity, for example by performing an assay to test forpesticidal activity. Generally, the protein is mixed and used in feedingassays. See, for example Marrone et al. (1985) J. of Economic Entomology78:290-293. Such assays can include contacting plants with one or morepests and determining the plant's ability to survive and/or cause thedeath of the pests. Examples of mutations that result in increasedtoxicity are found in Schnepf et al. (1998) Microbiol. Mol. Biol. Rev.62:775-806.

Alternatively, alterations may be made to the protein sequence of manyproteins at the amino or carboxy terminus without substantiallyaffecting activity. This can include insertions, deletions, oralterations introduced by modern molecular methods, such as PCR,including PCR amplifications that alter or extend the protein codingsequence by virtue of inclusion of amino acid encoding sequences in theoligonucleotides utilized in the PCR amplification. Alternatively, theprotein sequences added can include entire protein-coding sequences,such as those used commonly in the art to generate protein fusions. Suchfusion proteins are often used to (1) increase expression of a proteinof interest (2) introduce a binding domain, enzymatic activity, orepitope to facilitate either protein purification, protein detection, orother experimental uses known in the art (3) target secretion ortranslation of a protein to a subcellular organelle, such as theperiplasmic space of Gram-negative bacteria, or the endoplasmicreticulum of eukaryotic cells, the latter of which often results inglycosylation of the protein.

Variant nucleotide and amino acid sequences of the present inventionalso encompass sequences derived from mutagenic and recombinogenicprocedures such as DNA shuffling. With such a procedure, one or moredifferent delta-endotoxin or delta-endotoxin-associated protein codingregions can be used to create a new delta-endotoxin ordelta-endotoxin-associated protein possessing the desired properties. Inthis manner, libraries of recombinant polynucleotides are generated froma population of related sequence polynucleotides comprising sequenceregions that have substantial sequence identity and can be homologouslyrecombined in vitro or in vivo. For example, using this approach,sequence motifs encoding a domain of interest may be shuffled betweenthe delta-endotoxin or delta-endotoxin-associated gene of the inventionand other known delta-endotoxin or delta-endotoxin-associated genes toobtain a new gene coding for a protein with an improved property ofinterest, such as an increased insecticidal activity. Strategies forsuch DNA shuffling are known in the art. See, for example, Stemmer(1994) Proc. Natl. Acad. Sci. USA 91:10747-10751; Stemmer (1994) Nature370:389-391; Crameri et al. (1997) Nature Biotech. 15:436-438; Moore etal. (1997) J. Mol. Biol. 272:336-347; Zhang et al. (1997) Proc. Natl.Acad. Sci. USA 94:4504-4509; Crameri et al. (1998) Nature 391:288-291;and U.S. Pat. Nos. 5,605,793 and 5,837,458.

Domain swapping or shuffling is another mechanism for generating altereddelta-endotoxin or delta-endotoxin-associated proteins. Domains II andIII may be swapped between delta-endotoxin proteins, resulting in hybridor chimeric toxins with improved pesticidal activity or target spectrum.Methods for generating recombinant proteins and testing them forpesticidal activity are well known in the art (see, for example, Naimovet al. (2001) Appl. Environ. Microbiol. 67:5328-5330; de Maagd et al.(1996) Appl. Environ. Microbiol. 62:1537-1543; Ge et al. (1991) J. Biol.Chem. 266:17954-17958; Schnepf et al. (1990) J. Biol. Chem.265:20923-20930; Rang et al. 91999) Appl. Environ. Microbiol.65:2918-2925).

Plant Transformation

Transformation of plant cells can be accomplished by one of severaltechniques known in the art. First, one engineers the delta-endotoxin ordelta-endotoxin-associated gene in a way that allows its expression inplant cells. Typically a construct that expresses such a protein wouldcontain a promoter to drive transcription of the gene, as well as a 3′untranslated region to allow transcription termination andpolyadenylation. The organization of such constructs is well known inthe art. In some instances, it may be useful to engineer the gene suchthat the resulting peptide is secreted, or otherwise targeted within theplant cell. For example, the gene can be engineered to contain a signalpeptide to facilitate transfer of the peptide to the endoplasmicreticulum. It may also be preferable to engineer the plant expressioncassette to contain an intron, such that mRNA processing of the intronis required for expression.

Typically this ‘plant expression cassette’ will be inserted into a‘plant transformation vector’. This plant transformation vector may becomprised of one or more DNA vectors needed for achieving planttransformation. For example, it is a common practice in the art toutilize plant transformation vectors that are comprised of more than onecontiguous DNA segment. These vectors are often referred to in the artas ‘binary vectors’. Binary vectors as well as vectors with helperplasmids are most often used for Agrobacterium-mediated transformation,where the size and complexity of DNA segments needed to achieveefficient transformation is quite large, and it is advantageous toseparate functions onto separate DNA molecules. Binary vectors typicallycontain a plasmid vector that contains the cis-acting sequences requiredfor T-DNA transfer (such as left border and right border), a selectablemarker that is engineered to be capable of expression in a plant cell,and a ‘gene of interest’ (a gene engineered to be capable of expressionin a plant cell for which generation of transgenic plants is desired).Also present on this plasmid vector are sequences required for bacterialreplication. The cis-acting sequences are arranged in a fashion to allowefficient transfer into plant cells and expression therein. For example,the selectable marker gene and the gene of interest are located betweenthe left and right borders. Often a second plasmid vector contains thetrans-acting factors that mediate T-DNA transfer from Agrobacterium toplant cells. This plasmid often contains the virulence functions (Virgenes) that allow infection of plant cells by Agrobacterium, andtransfer of DNA by cleavage at border sequences and vir-mediated DNAtransfer, as in understood in the art (Hellens and Mullineaux (2000)Trends in Plant Science, 5:446-451). Several types of Agrobacteriumstrains (e.g. LBA4404, GV3101, EHA101, EHA105, etc.) can be used forplant transformation. The second plasmid vector is not necessary fortransforming the plants by other methods such as microprojection,microinjection, electroporation, polyethelene glycol, etc.

In general, plant transformation methods involve transferringheterologous DNA into target plant cells (e.g. immature or matureembryos, suspension cultures, undifferentiated callus, protoplasts,etc.), followed by applying a maximum threshold level of appropriateselection (depending on the selectable marker gene) to recover thetransformed plant cells from a group of untransformed cell mass.Explants are typically transferred to a fresh supply of the same mediumand cultured routinely. Subsequently, the transformed cells aredifferentiated into shoots after placing on regeneration mediumsupplemented with a maximum threshold level of selecting agent. Theshoots are then transferred to a selective rooting medium for recoveringrooted shoot or plantlet. The transgenic plantlet then grows into amature plant and produces fertile seeds (e.g. Hiei et al. (1994) ThePlant Journal 6: 271-282; Ishida et al. (1996) Nature Biotechnology 14:745-750). Explants are typically transferred to a fresh supply of thesame medium and cultured routinely. A general description of thetechniques and methods for generating transgenic plantlets are found inAyres and Park, 1994 (Critical Reviews in Plant Science 13: 219-239) andBommineni and Jauhar, 1997 (Maydica 42: 107-120). Since the transformedmaterial contains many cells; both transformed and non-transformed cellsare present in any piece of subjected target callus or tissue or groupof cells. The ability to kill non-transformed cells and allowtransformed cells to proliferate results in transformed plant cultures.Often, the ability to remove non-transformed cells is a limitation torapid recovery of transformed plant cells and successful generation oftransgenic plants.

Generation of transgenic plants may be performed by one of severalmethods, including but not limited to introduction of heterologous DNAby Agrobacterium into plant cells (Agrobacterium-mediatedtransformation), bombardment of plant cells with heterologous foreignDNA adhered to particles, and various other non-particle direct-mediatedmethods (e.g. Hiei et al. (1994) The Plant Journal 6: 271-282; Ishida etal. (1996) Nature Biotechnology 14: 745-750; Ayres and Park (1994)Critical Reviews in Plant Science 13: 219-239; Bommineni and Jauhar(1997) Maydica 42: 107-120) to transfer DNA.

Transformation protocols as well as protocols for introducing nucleotidesequences into plants may vary depending on the type of plant or plantcell, i.e., monocot or dicot, targeted for transformation. Suitablemethods of introducing nucleotide sequences into plant cells andsubsequent insertion into the plant genome include microinjection(Crossway et al. (1986) Biotechniques 4:320-334), electroporation (Riggset al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606,Agrobacterium-mediated transformation (U.S. Pat. No. 5,563,055; U.S.Pat. No. 5,981,840), direct gene transfer (Paszkowski et al. (1984) EMBOJ. 3:2717-2722), and ballistic particle acceleration (see, for example,U.S. Pat. No. 4,945,050; U.S. Pat. No. 5,879,918; U.S. Pat. No.5,886,244; U.S. Pat. No. 5,932,782; Tomes et al. (1995) “Direct DNATransfer into Intact Plant Cells via Microprojectile Bombardment,” inPlant Cell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborgand Phillips (Springer-Verlag, Berlin); McCabe et al. (1988)Biotechnology 6:923-926); aerosol beam transformation (U.S. PublishedApplication No. 20010026941; U.S. Pat. No. 4,945,050; InternationalPublication No. WO 91/00915; U.S. Published Application No. 2002015066);and Lec1 transformation (WO 00/28058). Also see Weissinger et al. (1988)Ann. Rev. Genet. 22:421-477; Sanford et al. (1987) Particulate Scienceand Technology 5:27-37; Christou et al. (1988) Plant Physiol.87:671-674; McCabe et al. (1988) Bio/Technology 6:923-926; Finer andMcMullen (1991) In Vitro Cell Dev. Biol. 27P: 175-182; Singh et al.(1998) Theor. Appl. Genet. 96:319-324 (soybean); Datta et al. (1990)Biotechnology 8:736-740; Klein et al. (1988) Proc. Natl. Acad. Sci. USA85:4305-4309; U.S. Pat. No. 5,240,855; U.S. Pat. Nos. 5,322,783 and5,324,646; Tomes et al. (1995) “Direct DNA Transfer into Intact PlantCells via Microprojectile Bombardment,” in Plant Cell, Tissue, and OrganCulture Fundamental Methods, ed. Gamborg (Springer-Verlag, Berlin);Klein et al. (1988) Plant Physiol. 91:440-444; Hooykaas-Van Slogteren etal. (1984) Nature (London) 311:763-764; U.S. Pat. No. 5,736,369;Bytebier et al. (1987) Proc. Natl. Acad. Sci. USA 84:5345-5349(Liliaceae); De Wet et al. (1985) in The Experimental Manipulation ofOvule Tissues, ed. Chapman et al. (Longman, N.Y.), pp. 197-209; Kaeppleret al. (1990) Plant Cell Reports 9:415-418 and Kaeppler et al. (1992)Theor. Appl. Genet. 84:560-566; D'Halluin et al. (1992) Plant Cell4:1495-1505; Li et al. (1993) Plant Cell Reports 12:250-255 and Christouand Ford (1995) Annals of Botany 75:407-413; Osjoda et al. (1996) NatureBiotechnology 14:745-750; all of which are herein incorporated byreference.

Following integration of heterologous foreign DNA into plant cells, onethen applies a maximum threshold level of appropriate selection in themedium to kill the untransformed cells and separate and proliferate theputatively transformed cells that survive from this selection treatmentby transferring regularly to a fresh medium. By continuous passage andchallenge with appropriate selection, one identifies and proliferatesthe cells that are transformed with the plasmid vector. Then molecularand biochemical methods will be used for confirming the presence of theintegrated heterologous gene of interest in the genome of transgenicplant.

The cells that have been transformed may be grown into plants inaccordance with conventional ways. See, for example, McCormick et al.(1986) Plant Cell Reports 5:81-84. These plants may then be grown, andeither pollinated with the same transformed strain or different strains,and the resulting hybrid having constitutive expression of the desiredphenotypic characteristic identified. Two or more generations may begrown to ensure that expression of the desired phenotypic characteristicis stably maintained and inherited and then seeds harvested to ensureexpression of the desired phenotypic characteristic has been achieved.In this manner, the present invention provides transformed seed (alsoreferred to as “transgenic seed”) having a nucleotide construct of theinvention, for example, an expression cassette of the invention, stablyincorporated into their genome.

The delta-endotoxin or delta-endotoxin-associated sequences of theinvention may be provided in expression cassettes for expression in theplant of interest. The cassette will include 5′ and 3′ regulatorysequences operably linked to a sequence of the invention. By “operablylinked” is intended a functional linkage between a promoter and a secondsequence, wherein the promoter sequence initiates and mediatestranscription of the DNA sequence corresponding to the second sequence.Generally, operably linked means that the nucleic acid sequences beinglinked are contiguous and, where necessary to join two protein codingregions, contiguous and in the same reading frame. The cassette mayadditionally contain at least one additional gene to be cotransformedinto the organism. Alternatively, the additional gene(s) can be providedon multiple expression cassettes.

Such an expression cassette is provided with a plurality of restrictionsites for insertion of the delta-endotoxin or delta-endotoxin-associatedsequence to be under the transcriptional regulation of the regulatoryregions.

The expression cassette will include in the 5′-3′ direction oftranscription, a transcriptional and translational initiation region(i.e., a promoter), a DNA sequence of the invention, and atranscriptional and translational termination region (i.e., terminationregion) functional in plants. The promoter may be native or analogous,or foreign or heterologous, to the plant host and/or to the DNA sequenceof the invention. Additionally, the promoter may be the natural sequenceor alternatively a synthetic sequence. Where the promoter is “native” or“homologous” to the plant host, it is intended that the promoter isfound in the native plant into which the promoter is introduced. Wherethe promoter is “foreign” or “heterologous” to the DNA sequence of theinvention, it is intended that the promoter is not the native ornaturally occurring promoter for the operably linked DNA sequence of theinvention.

The termination region may be native with the transcriptional initiationregion, may be native with the operably-linked DNA sequence of interest,may be native with the plant host, or may be derived from another source(i.e., foreign or heterologous to the promoter, the DNA sequence ofinterest, the plant host, or any combination thereof). Convenienttermination regions are available from the Ti-plasmid of A. tumefaciens,such as the octopine synthase and nopaline synthase termination regions.See also Guerineau et al. (1991) Mol. Gen. Genet. 262:141-144; Proudfoot(1991) Cell 64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149;Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene91:151-158; Ballas et al. (1989) Nucleic Acids Res. 17:7891-7903; andJoshi et al. (1987) Nucleic Acid Res. 15:9627-9639.

Where appropriate, the gene(s) may be optimized for increased expressionin the transformed host cell. That is, the genes can be synthesizedusing host cell-preferred codons for improved expression, or may besynthesized using codons at a host-preferred codon usage frequency.Generally, the GC content of the gene will be increased. See, forexample, Campbell and Gowri (1990) Plant Physiol. 92: 1-11 for adiscussion of host-preferred codon usage. Methods are known in the artfor synthesizing plant-preferred genes. See, for example, U.S. Pat. Nos.6,320,100; 6,075,185; 5,380,831; and 5,436,391, U.S. PublishedApplication Nos. 20040005600 and 20010003849, and Murray et al. (1989)Nucleic Acids Res. 17:477-498, herein incorporated by reference.

In one embodiment, the nucleic acids of interest are targeted to thechloroplast for expression. In this manner, where the nucleic acid ofinterest is not directly inserted into the chloroplast, the expressioncassette will additionally contain a nucleic acid encoding a transitpeptide to direct the gene product of interest to the chloroplasts. Suchtransit peptides are known in the art. See, for example, Von Heijne etal. (1991) Plant Mol. Biol. Rep. 9:104-126; Clark et al. (1989) J. Biol.Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol.84:965-968; Romer et al. (1993) Biochem. Biophys. Res. Commun.196:1414-1421; and Shah et al. (1986) Science 233:478-481.

Methods for transformation of chloroplasts are known in the art. See,for example, Svab et al. (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530;Svab and Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Svab andMaliga (1993) EMBO J. 12:601-606. The method relies on particle gundelivery of DNA containing a selectable marker and targeting of the DNAto the plastid genome through homologous recombination. Additionally,plastid transformation can be accomplished by transactivation of asilent plastid-bome transgene by tissue-preferred expression of anuclear-encoded and plastid-directed RNA polymerase. Such a system hasbeen reported in McBride et al. (1994) Proc. Natl. Acad. Sci. USA91:7301-7305.

The nucleic acids of interest to be targeted to the chloroplast may beoptimized for expression in the chloroplast to account for differencesin codon usage between the plant nucleus and this organelle. In thismanner, the nucleic acids of interest may be synthesized usingchloroplast-preferred codons. See, for example, U.S. Pat. No. 5,380,831,herein incorporated by reference.

Evaluation of Plant Transformation

Following introduction of heterologous foreign DNA into plant cells, thetransformation or integration of heterologous gene in the plant genomeis confirmed by various methods such as analysis of nucleic acids,proteins and metabolites associated with the integrated gene.

PCR Analysis: PCR analysis is a rapid method to screen transformedcells, tissue or shoots for the presence of incorporated gene at theearlier stage before transplanting into the soil (Sambrook and Russell,2001). PCR is carried out using oligonucleotide primers specific to thegene of interest or Agrobacterium vector background, etc.Southern Analysis Plant transformation is confirmed by Southern blotanalysis of genomic DNA (Sambrook and Russell, 2001). In general, totalDNA is extracted from the transformant, digested with appropriaterestriction enzymes, fractionated in an agarose gel and transferred to anitrocellulose or nylon membrane. The membrane or “blot” then is probedwith, for example, radiolabeled ³²P target DNA fragment to confirm theintegration of introduced gene in the plant genome according to standardtechniques (Sambrook and Russell, 2001. Molecular Cloning: A LaboratoryManual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.).Northern Analysis: RNA is isolated from specific tissues oftransformant, fractionated in a formaldehyde agarose gel, blotted onto anylon filter according to standard procedures that are routinely used inthe art (Sambrook, J., and Russell, D. W. 2001. Molecular Cloning: ALaboratory Manual, Cold Spring Harbor Laboratory Press, Cold SpringHarbor, N.Y.). Expression of RNA encoded by the delta-endotoxin ordelta-endotoxin-associated is then tested by hybridizing the filter to aradioactive probe derived from a delta-endotoxin ordelta-endotoxin-associated protein, by methods known in the art(Sambrook and Russell, 2001).Western blot and Biochemical assays: Western blot and biochemical assaysand the like may be carried out on the transgenic plants to confirm thepresence of protein encoded by the delta-endotoxin ordelta-endotoxin-associated gene by standard procedures (Sambrook, J.,and Russell, D. W. 2001. Molecular Cloning: A Laboratory Manual, ColdSpring Harbor Laboratory Press, Cold Spring Harbor, N.Y.) usingantibodies that bind to one or more epitopes present on thedelta-endotoxin or delta-endotoxin-associated protein.

Pesticidal Activity in Plants

In another aspect of the invention, one may generate transgenic plantsexpressing delta-endotoxin or delta-endotoxin-associated proteins thathave pesticidal activity. Methods described above by way of example maybe utilized to generate transgenic plants, but the manner in which thetransgenic plant cells are generated is not critical to this invention.Methods known or described in the art such as Agrobacterium-mediatedtransformation, aerosol beam, biolistic transformation, andnon-particle-mediated methods may be used at the discretion of theexperimenter. Plants expressing delta-endotoxin ordelta-endotoxin-associated proteins may be isolated by common methodsdescribed in the art, for example by transformation of callus, selectionof transformed callus, and regeneration of fertile plants from suchtransgenic callus. In such process, one may use any gene as a selectablemarker so long as its expression in plant cells confers ability toidentify or select for transformed cells.

A number of markers have been developed for use with plant cells, suchas resistance to chloramphenicol, the aminoglycoside G418, hygromycin,or the like. Other genes that encode a product involved in chloroplastmetabolism may also be used as selectable markers. For example, genesthat provide resistance to plant herbicides such as glyphosate,bromoxynil, or imidazolinone may find particular use. Such genes havebeen reported (Stalker et al. (1985) J. Biol. Chem. 263:6310-6314(bromoxynil resistance nitrilase gene); and Sathasivan et al. (1990)Nucl. Acids Res. 18:2188 (AHAS imidazolinone resistance gene).

Fertile plants expressing a delta-endotoxin or adelta-endotoxin-associated protein may be tested for pesticidalactivity, and the plants showing optimal activity selected for furtherbreeding. Methods are available in the art to assay for pest activity.Generally, the protein is mixed and used in feeding assays. See, forexample Marrone et al. (1985) J. of Economic Entomology 78:290-293.

Use in Pesticidal Control

General methods for employing the strains of the invention in pesticidecontrol or in engineering other organisms as pesticidal agents are knownin the art. See, for example U.S. Pat. No. 5,039,523 and EP 0480762A2.

The Bacillus strains of the invention or the microorganisms which havebeen genetically altered to contain the pesticidal gene and protein maybe used for protecting agricultural crops and products from pests. Inone aspect of the invention, whole, i.e., unlysed, cells of a toxin(pesticide)-producing organism are treated with reagents that prolongthe activity of the toxin produced in the cell when the cell is appliedto the environment of target pest(s).

Alternatively, the pesticide is produced by introducing a heterologousgene into a cellular host. Expression of the heterologous gene results,directly or indirectly, in the intracellular production and maintenanceof the pesticide. In one aspect of this invention, these cells are thentreated under conditions that prolong the activity of the toxin producedin the cell when the cell is applied to the environment of targetpest(s). The resulting product retains the toxicity of the toxin. Thesenaturally encapsulated pesticides may then be formulated in accordancewith conventional techniques for application to the environment hostinga target pest, e.g., soil, water, and foliage of plants. See, forexample EPA 0192319, and the references cited therein. Alternatively,one may formulate the cells expressing the genes of this invention suchas to allow application of the resulting material as a pesticide.

The active ingredients of the present invention are normally applied inthe form of compositions and can be applied to the crop area or plant tobe treated, simultaneously or in succession, with other compounds. Thesecompounds can be fertilizers, weed killers, cryoprotectants,surfactants, detergents, pesticidal soaps, dormant oils, polymers,and/or time-release or biodegradable carrier formulations that permitlong-term dosing of a target area following a single application of theformulation. They can also be selective herbicides, chemicalinsecticides, virucides, microbicides, amoebicides, pesticides,fungicides, bacteriocides, nematocides, mollusocides or mixtures ofseveral of these preparations, if desired, together with furtheragriculturally acceptable carriers, surfactants or application-promotingadjuvants customarily employed in the art of formulation. Suitablecarriers and adjuvants can be solid or liquid and correspond to thesubstances ordinarily employed in formulation technology, e.g. naturalor regenerated mineral substances, solvents, dispersants, wettingagents, tackifiers, binders or fertilizers. Likewise the formulationsmay be prepared into edible “baits” or fashioned into pest “traps” topermit feeding or ingestion by a target pest of the pesticidalformulation.

Preferred methods of applying an active ingredient of the presentinvention or an agrochemical composition of the present invention whichcontains at least one of the pesticidal proteins produced by thebacterial strains of the present invention are leaf application, seedcoating and soil application. The number of applications and the rate ofapplication depend on the intensity of infestation by the correspondingpest.

The composition may be formulated as a powder, dust, pellet, granule,spray, emulsion, colloid, solution, or such like, and may be preparableby such conventional means as desiccation, lyophilization, homogenation,extraction, filtration, centrifugation, sedimentation, or concentrationof a culture of cells comprising the polypeptide. In all suchcompositions that contain at least one such pesticidal polypeptide, thepolypeptide may be present in a concentration of from about 1% to about99% by weight.

Lepidopteran or coleopteran pests may be killed or reduced in numbers ina given area by the methods of the invention, or may be prophylacticallyapplied to an environmental area to prevent infestation by a susceptiblepest. Preferably the pest ingests, or is contacted with, apesticidally-effective amount of the polypeptide. By“pesticidally-effective amount” is intended an amount of the pesticidethat is able to bring about death to at least one pest, or to noticeablyreduce pest growth, feeding, or normal physiological development. Thisamount will vary depending on such factors as, for example, the specifictarget pests to be controlled, the specific environment, location,plant, crop, or agricultural site to be treated, the environmentalconditions, and the method, rate, concentration, stability, and quantityof application of the pesticidally-effective polypeptide composition.The formulations may also vary with respect to climatic conditions,environmental considerations, and/or frequency of application and/orseverity of pest infestation.

The pesticide compositions described may be made by formulating eitherthe bacterial cell, crystal and/or spore suspension, or isolated proteincomponent with the desired agriculturally-acceptable carrier. Thecompositions may be formulated prior to administration in an appropriatemeans such as lyophilized, freeze-dried, desiccated, or in an aqueouscarrier, medium or suitable diluent, such as saline or other buffer. Theformulated compositions may be in the form of a dust or granularmaterial, or a suspension in oil (vegetable or mineral), or water oroil/water emulsions, or as a wettable powder, or in combination with anyother carrier material suitable for agricultural application. Suitableagricultural carriers can be solid or liquid and are well known in theart. The term “agriculturally-acceptable carrier” covers all adjuvants,inert components, dispersants, surfactants, tackifiers, binders, etc.that are ordinarily used in pesticide formulation technology; these arewell known to those skilled in pesticide formulation. The formulationsmay be mixed with one or more solid or liquid adjuvants and prepared byvarious means, e.g., by homogeneously mixing, blending and/or grindingthe pesticidal composition with suitable adjuvants using conventionalformulation techniques. Suitable formulations and application methodsare described in U.S. Pat. No. 6,468,523, herein incorporated byreference.

“Pest” includes but is not limited to, insects, fungi, bacteria,nematodes, mites, ticks, and the like. Insect pests include insectsselected from the orders Coleoptera, Diptera, Hymenoptera, Lepidoptera,Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera,Isoptera, Anoplura, Siphonaptera, Trichoptera, etc., particularlyColeoptera, Lepidoptera, and Diptera.

Insect pests include insects selected from the orders Coleoptera,Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera,Orthoptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera,Trichoptera, etc., particularly Coleoptera and Lepidoptera. Insect pestsof the invention for the major crops include: Maize: Ostrinia nubilalis,European corn borer; Agrotis ipsilon, black cutworm; Helicoverpa zea,corn earworm; Spodoptera frugiperda, fall armyworm; Diatraeagrandiosella, southwestern corn borer; Elasmopalpus lignosellus, lessercornstalk borer; Diatraea saccharalis, surgarcane borer; Diabroticavirgifera, western corn rootworm; Diabrotica longicornis barberi,northern corn rootworm; Diabrotica undecimpunctata howardi, southerncorn rootworm; Melanotus spp., wireworms; Cyclocephala borealis,northern masked chafer (white grub); Cyclocephala immaculata, southernmasked chafer (white grub); Popillia japonica, Japanese beetle;Chaetocnema pulicaria, corn flea beetle; Sphenophorus maidis, maizebillbug; Rhopalosiphum maidis, corn leaf aphid; Anuraphis maidiradicis,corn root aphid; Blissus leucopterus leucopterus, chinch bug; Melanoplusfemurrubrum, redlegged grasshopper; Melanoplus sanguinipes, migratorygrasshopper; Hylemya platura, seedcorn maggot; Agromyza parvicornis,corn blot leafminer; Anaphothrips obscrurus, grass thrips; Solenopsismilesta, thief ant; Tetranychus urticae, twospotted spider mite;Sorghum: Chilo partellus, sorghum borer; Spodoptera frugiperda, fallarmyworm; Helicoverpa zea, corn earworm; Elasmopalpus lignosellus,lesser cornstalk borer; Feltia subterranea, granulate cutworm;Phyllophaga crinita, white grub; Eleodes, Conoderus, and Aeolus spp.,wireworms; Oulema melanopus, cereal leaf beetle; Chaetocnema pulicaria,corn flea beetle; Sphenophorus maidis, maize billbug; Rhopalosiphummaidis; corn leaf aphid; Siphaflava, yellow sugarcane aphid; Blissusleucopterus leucopterus, chinch bug; Contarinia sorghicola, sorghummidge; Tetranychus cinnabarinus, carmine spider mite; Tetranychusurticae, twospotted spider mite; Wheat: Pseudaletia unipunctata, armyworm; Spodoptera frugiperda, fall armyworm; Elasmopalpus lignosellus,lesser cornstalk borer; Agrotis orthogonia, western cutworm;Elasmopalpus lignosellus, lesser cornstalk borer; Oulema melanopus,cereal leaf beetle; Hypera punctata, clover leaf weevil; Diabroticaundecimpunctata howardi, southern corn rootworm; Russian wheat aphid;Schizaphis graminum, greenbug; Macrosiphum avenae, English grain aphid;Melanoplus femurrubrum, redlegged grasshopper; Melanoplusdifferentialis, differential grasshopper; Melanoplus sanguinipes,migratory grasshopper; Mayetiola destructor, Hessian fly; Sitodiplosismosellana, wheat midge; Meromyza americana, wheat stem maggot; Hylemyacoarctata, wheat bulb fly; Frankliniella fusca, tobacco thrips; Cephuscinctus, wheat stem sawfly; Aceria tulipae, wheat curl mite; Sunflower:Suleima helianthana, sunflower bud moth; Homoeosoma electellum,sunflower moth; zygogramma exclamationis, sunflower beetle; Bothyrusgibbosus, carrot beetle; Neolasioptera murtfeldtiana, sunflower seedmidge; Cotton: Heliothis virescens, cotton budworm; Helicoverpa zea,cotton bollworm; Spodoptera exigua, beet armyworm; Pectinophoragossypiella, pink bollworm; Anthonomus grandis, boll weevil; Aphisgossypii, cotton aphid; Pseudatomoscelis seriatus, cotton fleahopper;Trialeurodes abutilonea, bandedwinged whitefly; Lygus lineolaris,tarnished plant bug; Melanoplus femurrubrum, redlegged grasshopper;Melanoplus differentialis, differential grasshopper; Thrips tabaci,onion thrips; Franklinkiella fusca, tobacco thrips; Tetranychuscinnabarinus, carmine spider mite; Tetranychus urticae, twospottedspider mite; Rice: Diatraea saccharalis, sugarcane borer; Spodopterafrugiperda, fall armyworm; Helicoverpa zea, corn earworm; Colaspisbrunnea, grape colaspis; Lissorhoptrus oryzophilus, rice water weevil;Sitophilus oryzae, rice weevil; Nephotettix nigropictus, riceleafhopper; Blissus leucopterus leucopterus, chinch bug; Acrosternumhilare, green stink bug; Soybean: Pseudoplusia includens, soybeanlooper; Anticarsia gemmatalis, velvetbean caterpillar; Plathypenascabra, green cloverworm; Ostrinia nubilalis, European corn borer;Agrotis ipsilon, black cutworm; Spodoptera exigua, beet armyworm;Heliothis virescens, cotton budworm; Helicoverpa zea, cotton bollworm;Epilachna varivestis, Mexican bean beetle; Myzus persicae, green peachaphid; Empoasca fabae, potato leafhopper; Acrosternum hilare, greenstink bug; Melanoplus femurrubrum, redlegged grasshopper; Melanoplusdifferentialis, differential grasshopper; Hylemya platura, seedcornmaggot; Sericothrips variabilis, soybean thrips; Thrips tabaci, onionthrips; Tetranychus turkestani, strawberry spider mite; Tetranychusurticae, twospotted spider mite; Barley: Ostrinia nubilalis, Europeancorn borer; Agrotis ipsilon, black cutworm; Schizaphis graminum,greenbug; Blissus leucopterus leucopterus, chinch bug; Acrosternumhilare, green stink bug; Euschistus servus, brown stink bug; Deliaplatura, seedcorn maggot; Mayetiola destructor, Hessian fly; Petrobialatens, brown wheat mite; Oil Seed Rape: Brevicoryne brassicae, cabbageaphid; Phyllotreta cruciferae, Flea beetle; Mamestra configurata, Berthaarmyworm; Plutella xylostella, Diamond-back moth; Delia ssp., Rootmaggots.

Nematodes include parasitic nematodes such as root-knot, cyst, andlesion nematodes, including Heterodera spp., Meloidogyne spp., andGlobodera spp.; particularly members of the cyst nematodes, including,but not limited to, Heterodera glycines (soybean cyst nematode);Heterodera schachtii (beet cyst nematode); Heterodera avenae (cerealcyst nematode); and Globodera rostochiensis and Globodera pailida(potato cyst nematodes). Lesion nematodes include Pratylenchus spp.

The following examples are offered by way of illustration and not by wayof limitation.

EXPERIMENTAL Example 1 Extraction of Plasmid DNA

A pure culture of strain ATX13026 was grown in large quantities of richmedia. The culture was spun to harvest the cell pellet. The cell pelletwas then prepared by treatment with SDS by methods known in the art,resulting in breakage of the cell wall and release of DNA. Proteins andlarge genomic DNA was then precipitated by a high salt concentration.The plasmid DNA was then precipitated by standard ethanol precipitation.The plasmid DNA was separated from any remaining chromosomal DNA byhigh-speed centrifugation through a cesium chloride gradient. The DNAwas visualized in the gradient by UV light and the band of lower density(i.e. the lower band) was extracted using a syringe. This band containedthe plasmid DNA from strain ATX 13026. The quality of the DNA waschecked by visualization on an agarose gel by methods known in the art.

Example 2 Cloning of Genes

The purified plasmid DNA was sheared into 5-10 kb sized fragments andthe 5′ and 3′ single stranded overhangs repaired using T4 DNA polymeraseand Klenow fragment in the presence of all four dNTPs, as known in theart. Phosphates were then attached to the 5′ ends by treatment with T4polynucleotide kinase, as known in the art. The repaired DNA fragmentswere then ligated overnight into a standard high copy vector (i.e.pBluescript SK+), suitably prepared to accept the inserts as known inthe art (for example by digestion with a restriction enzyme producingblunt ends).

The quality of the library was analyzed by digesting a subset of cloneswith a restriction enzyme known to have a cleavage site flanking thecloning site. A high percentage of clones were determined to containinserts, with an average insert size of 5-6 kb.

Example 3 High Throughput Sequencing of Library Plates

Once the shotgun library quality was checked and confirmed, colonieswere grown in a rich broth in 2 ml 96-well blocks overnight at 37° C. ata shaking speed of 350 rpm. The blocks were spun to harvest the cells tothe bottom of the block. The blocks were then prepared by standardalkaline lysis prep in a high throughput format.

The end sequences of clones from this library were then determined for alarge number of clones from each block in the following way: The DNAsequence of each clone chosen for analysis was determined using thefluorescent dye terminator sequencing technique (Applied Biosystems) andstandard primers flanking each side of the cloning site. Once thereactions had been carried out in the thermocycler, the DNA wasprecipitated using standard ethanol precipitation. The DNA wasresuspended in water and loaded onto a capillary sequencing machine.Each library plate of DNA was sequenced from either end of the cloningsite, yielding two reads per plate over each insert.

Example 4 Assembly and Screening of Sequencing Data

DNA sequences obtained were compiled into an assembly project andaligned together to form contigs. This can be done efficiently using acomputer program, such as Vector NTi, or alternatively by using thePred/Phrap suite of DNA alignment and analysis programs. These contigs,along with any individual read that may not have been added to a contig,were compared to a compiled database of all classes of known pesticidalgenes. Contigs or individual reads identified as having identity to aknown endotoxin or pesticidal gene were analyzed further. Among thesequences obtained, clone pAX008 contained DNA identified as havinghomology to known endotoxin genes. Therefore, pAX008 was selected forfurther sequencing.

Example 5 Sequencing of pAX008 and Identification of AXMI-008

Primers were designed to anneal to pAX008, in a manner such that DNAsequences generated from such primers will overlap existing DNA sequenceof the clone(s). This process, known as “oligo walking,” is well knownin the art. This process was utilized to determine the entire DNAsequence of the region exhibiting homology to a known endotoxin gene. Inthe case of pAX008, this process was used to determine the DNA sequenceof the entire clone, resulting in a single nucleotide sequence. Thecompleted DNA sequence was then placed back into the original largeassembly for further validation. This allowed incorporation of more DNAsequence reads into the contig, resulting in multiple reads of coverageover the entire region.

Analysis of the DNA sequence of pAX008 by methods known in the artidentified an open reading frame with homology to known delta endotoxingenes. This open reading frame is designated as AXMI-008. The DNAsequence of AXMI-008 is provided as SEQ ID NO:1, and the amino acidsequence of the predicted AMXI-008 protein is provided in SEQ ID NO:3.An alternate start site for AXMI-008 at nucleotide 177 of SEQ ID NO:1generates the amino acid sequence provided as SEQ ID NO:5. Furtheranalysis identified an open reading frame immediately 3′ to the end ofthe AXMI-008 open reading frame. This predicted amino acid sequence ofthis orf, referred to herein as AXMI-008orf2, is provided in SEQ IDNO:7.

Example 6 Homology of AXMI-008 to Known Endotoxin Genes

Searches of DNA and protein databases with the DNA sequence and aminoacid sequence of AXMI-008 reveal that AXMI-008 is homologous to knownendotoxins.

Blast searches identify cry40Aa as having the strongest block ofhomology, and alignment of AMXI-008 protein (SEQ ID NO:3) to a large setof endotoxin proteins shows that the most homologous proteins iscry40Aa. The overall amino acid identity of cry40Aa to AXMI-008 is 66%(see Table 1). Inspection of the amino acid sequence of AXMI-008suggests that it does not contain a C-terminal non-toxic domain as ispresent in several endotoxin families. By removing this C-terminalprotein of the toxins from the alignment, the alignment reflects theamino acid identify present solely in the toxin domains (see Table 1,column three). This ‘trimmed’ alignment is shown in FIG. 1.

TABLE 1 Amino Acid Identity of AXMI-008 with Exemplary Endotoxin ClassesPercent Amino Acid Percent Amino Acid Identity of Endotoxin Identity toAXMI-008 truncated Toxins to AXMI-008 cry1Aa 11% 20% cry1Ac 11% 20%cry1Ia 22% 22% cry2A 10% 10% cry3Aa 21% 21% cry3Bb 21% 21% cry4Aa 13%21% cry4Ba 13% 20% cry6Aa 5% 5% cry7Aa 12% 20% cry8Aa 13% 22% cry10Aa20% 20% cry16Aa 22% 22% cry19Ba 21% 22% cry24Aa 26% 26% cry25Aa 23% 23%cry39Aa 25% 25% cry40Aa 66% 66%

Example 7 The ORF Immediately Downstream of AXMI-008 is Homologous toDownstream ORFs of Several Endotoxins

The open reading frame immediately downstream (3′) to the AXMI-008coding region has homology to known endotoxin-related proteins. Blastsearches identify crybun3orf2 (the downstream orf of cry40Aa) as havingthe strongest block of homology. Several other orf-2 like proteins arepresent in databases, and an alignment of AMXI-008 protein (SEQ ID NO:3)to a set of these proteins is shown in FIG. 2. These proteins also sharehomology to the C-terminal non-toxic domain of cry4Aa and cry4Ba. Theoverall amino acid identity of AXMI-8-orf2 to cry40Aaorf2 is 86% (seeTable 2).

TABLE 2 Amino acid identity of AXMI-008-orf2 to related proteins Percentamino acid identity Protein to AXMI-008-orf2 crybun3orf2 (cry40Aa orf2)86% crybun2orf2 (cry39Aa orf2) 85% cry19Aorf2 62% C-terminus cry4Aa 53%C-terminus cry4Ba 54%

Example 8 Assays for Pesticidal Activity

The ability of a pesticidal protein to act as a pesticide upon a pest isoften assessed in a number of ways. One way well known in the art is toperform a feeding assay. In such a feeding assay, one exposes the pestto a sample containing either compounds to be tested, or controlsamples. Often this is performed by placing the material to be tested,or a suitable dilution of such material, onto a material that the pestwill ingest, such as an artificial diet. The material to be tested maybe composed of a liquid, solid, or slurry. The material to be tested maybe placed upon the surface and then allowed to dry. Alternatively, thematerial to be tested may be mixed with a molten artificial diet, thendispensed into the assay chamber. The assay chamber may be, for example,a cup, a dish, or a well of a microtiter plate.

Assays for sucking pests (for example aphids) may involve separating thetest material from the insect by a partition, ideally a portion that canbe pierced by the sucking mouthparts of the sucking insect, to allowingestion of the test material. Often the test material is mixed with afeeding stimulant, such as sucrose, to promote ingestion of the testcompound.

Other types of assays can include microinjection of the test materialinto the mouth, or gut of the pest, as well as development of transgenicplants, followed by test of the ability of the pest to feed upon thetransgenic plant. Plant testing may involve isolation of the plant partsnormally consumed, for example, small cages attached to a leaf, orisolation of entire plants in cages containing insects.

Other methods and approaches to assay pests are known in the art, andcan be found, for example in Robertson, J. L. & H. K. Preisler. 1992.Pesticide bioassays with arthropods. CRC, Boca Raton, Fla.Alternatively, assays are commonly described in the journals “ArthropodManagement Tests” and “Journal of Economic Entomology” or by discussionwith members of the Entomological Society of America (ESA).

Example 9 Bioassay of pAX008 on Trichoplusia ni Cabbage Looper

An Escherichia coli strain containing pAX008, as well as a culture ofuntransformed Escherichia coli were grown in 2 ml of LB Broth(Luria-Bertani Broth, Becton Dickinson & Company, Sparks, Md.) for 24hours at 37° C. with agitation at 250 rpm. pAX-008 was grown in LBcontaining the appropriate antibiotic to select for maintenance of theplasmid in E. coli.

Bioassays were performed using artificial diet (Multiple Species Diet,Southland Products, Lake Village, Ark.) in 24 well tissue cultureplates. Bioassays were carried out by applying the Escherichia coliculture containing pAX-008 to the diet surface and allowing the dietsurface to dry. The strains were applied as whole cultures to the dietat a concentration of 40 μl of culture per well. The bioassays were heldin the dark at 25° C. and 65% relative humidity. Trays were sealed withBreathe Easy Sealing Tape (Diversified Biotech, Boston, Mass.). Resultswere recorded at 5 days.

TABLE 3 Assay of AXMI-008 clone pAX008 on T. ni Sample # Dead/Total %Mortality pAX-008 6/6  100% Negative Control 0/13 0%

Example 10 Expression of AXMI-008 in Bacillus

The 1,890 base pair insecticidal axmi008 gene was amplified by PCR frompAX008, and cloned into the Bacillus Expression vector pAX922 by methodswell known in the art. The resulting clone, pAX922, expressed AXMI-008protein when transformed into cells of a cry(−) Bacillus thuringiensisstrain. The Bacillus strain containing pAX922 and expressing theAXMI-008 insecticidal protein may be cultured on a variety ofconventional growth media. A Bacillus strain containing pAX922 was grownin CYS media (10 g/l Bacto-casitone; 3 g/l yeast extract; 6 g/l KH₂PO₄;14 g/l K₂HPO₄; 0.5 mM MgSO₄; 0.05 mM MnCl₂; 0.05 mM FeSO₄), untilsporulation was evident by microscopic examination. Samples wereprepared, and AXMI-008 was tested for insecticidal activity in bioassaysagainst important insect pests.

Example 11 Bioassay of AXMI-008 on Tenebrio molitor

Samples of Bacillus cultures expressing AXMI-008 were prepared andtested for pesticidal activity on Tenebrio molitor. When pAX 922 isprepared as an insoluble fraction at pH 4.0 it showed activity againstcommonly called the yellow mealworm.

Samples of AXMI-008 were prepared from a culture of a Bacillus straincontaining pAX 922. The bioassay sample was prepared by growing aculture in CYS media for 4 days, until sporulation. The sample wascentrifuged at 10,000 rpm for 10 minutes and the supernatant discarded.The pellet was washed in 20 mM Tris pH 8 and spun at 10,000 rpm for 10minutes. The supernatant was discarded and the pellet resuspended in 3mls of 50 mM Sodium Citrate and 25 mM Sodium Chloride with 2 mM DTT atpH 4. The sample was incubated at 37° C. for 1 hour. After incubationthe sample was spun at 13,000 rpm for 10 minutes and the supernatantdiscarded. The pellet was resuspended in 50 mM Sodium Citrate and 25 mMSodium Chloride at pH 4.

Bioassays of samples on Tenebrio molitor were performed on an artificialdiet (Southern Corn Rootworm Diet, Bioserv, Frenchtown, N.J., #F9757B)in 24 well tissue culture plates. The sample was applied as a surfacetreatment with a concentration of Axmi008 at 8 ug/cm² and allowed to airdry. The insects were applied using a fine tip brush. Bioassay trayswere sealed with Breathe Easy Sealing Tape (Diversified Biotech, Boston,Mass.) and incubated without light at 65% relative humidity, 25° C. forseven days and results recorded.

TABLE 4 Assay of AXMI-008 clone pAX008 on T. molitor Sample # Dead/Total% Mortality pAX922 3 of 4 75%* *Remaining Tenebrio molitor was stunted.Stunting is observed as reduced larval size and growth, and severelyreduced or minimal feeding. The insect may also demonstrate avoidance ofthe treated diet compared to the untreated diet.

Methods

To prepare CYS media: 10 g/l Bacto-casitone; 3 g/l yeast extract; 6 g/lKH₂PO₄; 14 g/l K₂HPO₄; 0.5 mM MgSO₄; 0.05 mM MnCl₂; 0.05 mM FeSO₄. TheCYS mix should be pH 7, if adjustment is necessary. NaOH or HCl arepreferred. The media is then autoclaved and 100 ml of 10× filteredglucose is added after autoclaving. If the resultant solution is cloudyit can be stirred at room temperature to clear.

Example 12 Vectoring of AXMI-008 for Plant Expression

The AXMI-008 coding region DNA is operably connected with appropriatepromoter and terminator sequences for expression in plants. Suchsequences are well known in the art and may include the rice actinpromoter or maize ubiquitin promoter for expression in monocots, theArabidopsis UBQ3 promoter or CaMV 35S promoter for expression in dicots,and the nos or PinII terminators. Techniques for producing andconfirming promoter-gene-terminator constructs also are well known inthe art.

The plant expression cassettes described above are combined with anappropriate plant selectable marker to aid in the selections oftransformed cells and tissues, and ligated into plant transformationvectors. These may include binary vectors from Agrobacterium-mediatedtransformation or simple plasmid vectors for aerosol or biolistictransformation.

Example 13 Transformation of Maize Cells with AXMI-008

Maize ears are collected 8-12 days after pollination. Embryos areisolated from the ears, and those embryos 0.8-1.5 mm in size are usedfor transformation. Embryos are plated scutellum side-up on a suitableincubation media, such as DN62A5S media (3.98 g/L N6 Salts; 1 mL/L (of1000× Stock) N6 Vitamins; 800 mg/L L-Asparagine; 100 mg/L Myo-inositol;1.4 g/L L-Proline; 100 mg/L Casaminoacids; 50 g/L sucrose; 1 mL/L (of 1mg/mL Stock) 2,4-D), and incubated overnight at 25° C. in the dark.

The resulting explants are transferred to mesh squares (30-40 perplate), transferred onto osmotic media for 30-45 minutes, thentransferred to a beaming plate (see, for example, PCT Publication No.WO/0138514 and U.S. Pat. No. 5,240,842).

DNA constructs designed to express AXMI-008 in plant cells areaccelerated into plant tissue using an aerosol beam accelerator, usingconditions essentially as described in PCT Publication No. WO/0138514.After beaming, embryos are incubated for 30 min on osmotic media, thenplaced onto incubation media overnight at 25° C. in the dark. To avoidunduly damaging beamed explants, they are incubated for at least 24hours prior to transfer to recovery media. Embryos are then spread ontorecovery period media, for 5 days, 25° C. in the dark, then transferredto a selection media. Explants are incubated in selection media for upto eight weeks, depending on the nature and characteristics of theparticular selection utilized. After the selection period, the resultingcallus is transferred to embryo maturation media, until the formation ofmature somatic embryos is observed. The resulting mature somatic embryosare then placed under low light, and the process of regeneration isinitiated by methods known in the art. The resulting shoots are allowedto root on rooting media, and the resulting plants are transferred tonursery pots and propagated as transgenic plants.

Materials

DN62A5S Media Components per liter Source Chu'S N6 Basal 3.98 g/LPhytotechnology Labs Salt Mixture (Prod. No. C 416) Chu's N6 1 mL/LPhytotechnology Labs Vitamin (of 1000x Stock) Solution (Prod. No. C 149)L-Asparagine 800 mg/L Phytotechnology Labs Myo-inositol 100 mg/L SigmaL-Proline 1.4 g/L Phytotechnology Labs Casaminoacids 100 mg/L FisherScientific Sucrose 50 g/L Phytotechnology Labs 2,4-D (Prod. No. 1 mL/LSigma D-7299) (of 1 mg/mL Stock)

Adjust the pH of the solution to pH to 5.8 with 1N KOH/1N KCl, addGelrite (Sigma) to 3 g/L, and autoclave. After cooling to 50° C., add 2ml/L of a 5 mg/ml stock solution of Silver Nitrate (PhytotechnologyLabs). Recipe yields about 20 plates.

Example 14 Transformation of AXMI-008 into Plant Cells byAgrobacterium-Mediated Transformation

Ears are collected 8-12 days after pollination. Embryos are isolatedfrom the ears, and those embryos 0.8-1.5 mm in size are used fortransformation. Embryos are plated scutellum side-up on a suitableincubation media, and incubated overnight at 25° C. in the dark.However, it is not necessary per se to incubate the embryos overnight.Embryos are contacted with an Agrobacterium strain containing theappropriate vectors for Ti plasmid mediated transfer for 5-10 min, andthen plated onto co-cultivation media for 3 days (25° C. in the dark).After co-cultivation, explants are transferred to recovery period mediafor five days (at 25° C. in the dark). Explants are incubated inselection media for up to eight weeks, depending on the nature andcharacteristics of the particular selection utilized. After theselection period, the resulting callus is transferred to embryomaturation media, until the formation of mature somatic embryos isobserved. The resulting mature somatic embryos are then placed under lowlight, and the process of regeneration is initiated as known in the art.The resulting shoots are allowed to root on rooting media, and theresulting plants are transferred to nursery pots and propagated astransgenic plants.

All publications and patent applications mentioned in the specificationare indicative of the level of skill of those skilled in the art towhich this invention pertains. All publications and patent applicationsare herein incorporated by reference to the same extent as if eachindividual publication or patent application was specifically andindividually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail byway of illustration and example for purposes of clarity ofunderstanding, it will be obvious that certain changes and modificationsmay be practiced within the scope of the appended claims.

1. An isolated polypeptide selected from the group consisting of: a) apolypeptide comprising the amino acid sequence of SEQ ID NO:3 or 5; b) apolypeptide encoded by the nucleotide sequence of SEQ ID NO:1, 2, or 4,wherein said polypeptide has pesticidal activity; c) a polypeptidecomprising an amino acid sequence having at least 90% sequence identityto the amino acid sequence of SEQ ID NO:3 or 5, wherein said polypeptidehas pesticidal activity; and, d) a polypeptide that is encoded by anucleotide sequence that is at least 90% identical to the nucleotidesequence of SEQ ID NO:1, 2, or 4, wherein said polypeptide haspesticidal activity.
 2. The polypeptide of claim 1, wherein saidpolypeptide is selected from the group consisting of: a) a polypeptidecomprising an amino acid sequence having at least 95% sequence identityto the amino acid sequence of SEQ ID NO:3 or 5, wherein said polypeptidehas pesticidal activity; and, b) a polypeptide that is encoded by anucleotide sequence that is at least 95% identical to the nucleotidesequence of SEQ ID NO:1, 2, or 4, wherein said polypeptide haspesticidal activity.
 3. The polypeptide of claim 1, further comprising aheterologous amino acid sequence.
 4. An antibody that selectively bindsto a polypeptide of claim
 1. 5. A composition comprising the polypeptideof claim
 1. 6. The composition of claim 5, wherein said composition isselected from the group consisting of a powder, dust, pellet, granule,spray, emulsion, colloid, and solution.
 7. The composition of claim 6,wherein said composition is prepared by desiccation, lyophilization,homogenization, extraction, filtration, centrifugation, sedimentation,or concentration of a culture of Bacillus thuringiensis cells.
 8. Thecomposition of claim 6, comprising from about 1% to about 99% by weightof said polypeptide.
 9. A method for controlling a lepidopteran orcoleopteran pest population comprising contacting said population with apesticidally-effective amount of a polypeptide of claim
 1. 10. A methodfor killing a lepidopteran or coleopteran pest, comprising contactingsaid pest with, or feeding to said pest, a pesticidally-effective amountof a polypeptide of claim
 1. 11. An isolated polypeptide selected fromthe group consisting of: a) a polypeptide comprising the amino acidsequence of SEQ ID NO:7; b) a polypeptide encoded by the nucleotidesequence of SEQ ID NO:6, wherein said polypeptide has delta-endotoxinassociated activity; c) a polypeptide comprising an amino acid sequencehaving at least 90% sequence identity to the amino acid sequence of SEQID NO:7, wherein said polypeptide is a delta-endotoxin associatedpolypeptide; and, d) a polypeptide that is encoded by a nucleotidesequence that is at least 90% identical to the nucleotide sequence ofSEQ ID NO:6, wherein said polypeptide is a delta-endotoxin associatedpolypeptide.
 12. The polypeptide of claim 1, wherein said polypeptide isselected from the group consisting of: a) a polypeptide comprising anamino acid sequence having at least 95% sequence identity to the aminoacid sequence of SEQ ID NO:7, wherein said polypeptide has pesticidalactivity; and, b) a polypeptide that is encoded by a nucleotide sequencethat is at least 95% identical to the nucleotide sequence of SEQ IDNO:6, wherein said polypeptide has pesticidal activity.
 13. Thepolypeptide of claim 12, further comprising a heterologous amino acidsequence.
 14. An antibody that selectively binds to a polypeptide ofclaim
 12. 15. The composition of claim 5 further comprising: a) apolypeptide comprising the amino acid sequence of SEQ ID NO:7; b) apolypeptide encoded by the nucleotide sequence of SEQ ID NO:6, whereinsaid polypeptide has delta-endotoxin associated activity; c) apolypeptide comprising an amino acid sequence having at least 90%sequence identity to the amino acid sequence of SEQ ID NO:7, whereinsaid polypeptide is a delta-endotoxin associated polypeptide; or, d) apolypeptide that is encoded by a nucleotide sequence that is at least90% identical to the nucleotide sequence of SEQ ID NO:6, wherein saidpolypeptide is a delta-endotoxin associated polypeptide.
 16. Thecomposition of claim 6 further comprising: a) a polypeptide comprisingthe amino acid sequence of SEQ ID NO:7; b) a polypeptide encoded by thenucleotide sequence of SEQ ID NO:6, wherein said polypeptide hasdelta-endotoxin associated activity; c) a polypeptide comprising anamino acid sequence having at least 90% sequence identity to the aminoacid sequence of SEQ ID NO:7, wherein said polypeptide is adelta-endotoxin associated polypeptide; or, d) a polypeptide that isencoded by a nucleotide sequence that is at least 90% identical to thenucleotide sequence of SEQ ID NO:6, wherein said polypeptide is adelta-endotoxin associated polypeptide.
 17. The composition of claim 7further comprising: a) a polypeptide comprising the amino acid sequenceof SEQ ID NO:7; b) a polypeptide encoded by the nucleotide sequence ofSEQ ID NO:6, wherein said polypeptide has delta-endotoxin associatedactivity; c) a polypeptide comprising an amino acid sequence having atleast 90% sequence identity to the amino acid sequence of SEQ ID NO:7,wherein said polypeptide is a delta-endotoxin associated polypeptide;or, d) a polypeptide that is encoded by a nucleotide sequence that is atleast 90% identical to the nucleotide sequence of SEQ ID NO:6, whereinsaid polypeptide is a delta-endotoxin associated polypeptide.
 18. Thecomposition of claim 8 further comprising: a) a polypeptide comprisingthe amino acid sequence of SEQ ID NO:7; b) a polypeptide encoded by thenucleotide sequence of SEQ ID NO:6, wherein said polypeptide hasdelta-endotoxin associated activity; c) a polypeptide comprising anamino acid sequence having at least 90% sequence identity to the aminoacid sequence of SEQ ID NO:7, wherein said polypeptide is adelta-endotoxin associated polypeptide; or, d) a polypeptide that isencoded by a nucleotide sequence that is at least 90% identical to thenucleotide sequence of SEQ ID NO:6, wherein said polypeptide is adelta-endotoxin associated polypeptide.
 19. The method of claim 9wherein said population is further contacted with apesticidally-effective amount of a polypeptide selected from the groupconsisting of: a) a polypeptide comprising the amino acid sequence ofSEQ ID NO:7; b) a polypeptide encoded by the nucleotide sequence of SEQID NO:6, wherein said polypeptide has delta-endotoxin associatedactivity; c) a polypeptide comprising an amino acid sequence having atleast 90% sequence identity to the amino acid sequence of SEQ ID NO:7,wherein said polypeptide is a delta-endotoxin associated polypeptide;and, d) a polypeptide that is encoded by a nucleotide sequence that isat least 90% identical to the nucleotide sequence of SEQ ID NO:6,wherein said polypeptide is a delta-endotoxin associated polypeptide.20. The method of claim 10 wherein said population is further contactedwith a pesticidally-effective amount of a polypeptide selected from thegroup consisting of: a) a polypeptide comprising the amino acid sequenceof SEQ ID NO:7; b) a polypeptide encoded by the nucleotide sequence ofSEQ ID NO:6, wherein said polypeptide has delta-endotoxin associatedactivity; c) a polypeptide comprising an amino acid sequence having atleast 90% sequence identity to the amino acid sequence of SEQ ID NO:7,wherein said polypeptide is a delta-endotoxin associated polypeptide;and, d) a polypeptide that is encoded by a nucleotide sequence that isat least 90% identical to the nucleotide sequence of SEQ ID NO:6,wherein said polypeptide is a delta-endotoxin associated polypeptide.